# MarketFlow Predictive Usefulness Acceptance Readiness Review Using Improved Evidence Status

## Review Package

- Artifact/status: `PREDICTIVE_USEFULNESS_ACCEPTANCE_READINESS_REVIEW_USING_IMPROVED_EVIDENCE` / `PREDICTIVE_USEFULNESS_ACCEPTANCE_READINESS_REVIEW_USING_IMPROVED_EVIDENCE_COMPLETED`.
- Schema: `predictive_usefulness_acceptance_readiness_review_using_improved_evidence_v1`.
- Decision: `PREDICTIVE_USEFULNESS_ACCEPTANCE_NOT_READY_USING_IMPROVED_EVIDENCE`.
- Reason: `SMALL_CROSS_SECTIONAL_EDGE_LOCAL_MODEL_MATCHES_MAJORITY_AND_OPTIONAL_MODEL_COVERAGE_INCOMPLETE`.
- Readiness digest: `e3a8803e6a72a45c4b0355bd0c8870917496325f4c9718bb977156611d5713f0`.
- Checklist: `84 / 84` passed, `0` failed, `0` blockers.
- The review is deterministic, offline, research-only, non-actionable, and operator-review-required.

## Source Reassessment and Bound Evidence

- Source artifact/status: `PREDICTIVE_USEFULNESS_REASSESSMENT_RERUN_USING_IMPROVED_EVIDENCE_PACKAGE` / `PREDICTIVE_USEFULNESS_REASSESSMENT_RERUN_USING_IMPROVED_EVIDENCE_PACKAGE_READY`.
- Source reassessment digest: `1ccd45069f10284923c0ac2e93f02d0a5d787c78a1f9d7feb216855fd44356e5`.
- Results-review/execution/output-binding/approval digests: `75a69f5a20a4309dcfe4d9e82333d0348f8459e4ecfe2ac3a9f4373d4af3551f` / `b6e6429fefd2d8b0ed450845d104aab415e0142740d62bd49fc76678677aab17` / `d6d272c9369430546c73f96d220c3e33183631de98a0a5cf9471c9179bf0710a` / `c2ce4254de6c4fa3934a6c1fddb04f8bad334054ba914119c915f6b6071c558f`.
- The complete improved-evidence planning, redesign, target-definition, prior readiness/reassessment, predictive-evidence, matrix, feature, label, registry, and records digest chain remains bound.
- The reassessment remains immutable source evidence and was not rerun.

## Dataset and Evidence

- Dataset/profile/range: `expanded_universe_canonical_dataset_v1` / `RTH_FULL_SESSION_1D` / `2022-01-01` through `2025-12-31`.
- Ordered universe: `MSFT`, `NVDA`, `AMZN`, `GOOGL`, `META`, `TSLA`, `JPM`, `XOM`, `JNJ`, `WMT`, `CAT`, `LMT`.
- Records: `11946`; META remains `913` and every other ticker remains `1003`.
- Matrix/evaluable/unavailable/OOS rows: `143352 / 142200 / 1152 / 34848`.
- Majority/local/cross-sectional accuracy: `0.58626033 / 0.58626033 / 0.58935950`; cross-sectional delta: `0.00309917`.
- Majority/local/cross-sectional Brier: `0.04867526 / 0.04867526 / 0.04831065`.
- Optional tree and ensemble families remain unavailable. Eight leakage controls passed with zero failures.

## Readiness Criteria and Classification

- Fifteen criteria preserve the required pass, not-met, operator-review, and META-awareness findings.
- Signal, baseline outperformance, local model, cross-sectional edge, and OOS readiness are `NOT_READY`.
- Walk-forward and calibration/Brier readiness require operator review.
- Leakage readiness is `PASS`; META readiness is `PASS_WITH_OPERATOR_AWARENESS`.
- The small cross-sectional edge, local-model equivalence, and incomplete optional-model coverage do not support acceptance readiness.
- `additional_evidence_or_method_improvement_required` is true.

## Per-Ticker Readiness

All 12 ordered ticker entries are `NOT_READY` and independently digest-bound. Each preserves the frozen record count and closed acceptance, profitability, runtime, strategy, paper-trading, broker, regeneration, recomputation, and training gates. META carries `PRESERVE_META_LIMITATION_IN_ACCEPTANCE_READINESS_REVIEW_USING_IMPROVED_EVIDENCE`.

## Next Chain and Risk Controls

- The follow-on `Predictive Usefulness Not-Ready Closure and Method Planning Tree Using Improved Evidence v1` is implemented as a separate offline, digest-bound artifact.
- This readiness review remains immutable source evidence.
- The current improved-evidence acceptance path is closed as not ready.
- The closure creates no acceptance candidate, does not accept predictive usefulness or profitability, and does not authorize runtime.
- Any method or evidence improvement requires separate operator selection, review, and approval.
- A reassessment and readiness review may be rerun only after separately approved new evidence.
- An acceptance candidate remains closed unless a future readiness review passes.
- All 26 risk controls preserve research-only scope, non-mutation, no reruns/recomputation/training, and closed acceptance/runtime/trading authority.

## Authority Boundary

- The acceptance-readiness review is completed, but readiness remains false.
- No acceptance candidate or acceptance ceremony was created or allowed.
- Predictive usefulness and profitability remain `not accepted`.
- Runtime, strategy, paper trading, and broker execution remain `NOT_AUTHORIZED`.
- No provider request, acquisition, regeneration, source mutation, predictive execution, reassessment rerun, scoring, recommendation, runtime, broker, or trading action occurred.
